首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1643909

全球静脉支架市场 - 2025-2033

Global Venous Stents Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球静脉支架市场规模达12.4亿美元，预计2033年将达26.2亿美元，2025-2033年预测期间复合年增长率为8.5%。

静脉支架是可扩张的金属网管，可对阻塞或狭窄的静脉壁施加压力，并作为支架以保持静脉畅通。它们通常放置在腹部、胸部和腿部较大的中央静脉中。静脉支架用于治疗慢性深部静脉栓塞（DVT）、血液透析/动静脉瘻管、梅-瑟纳症候群、胡桃夹症候群和血栓后症候群。 DVT 被定义为在一根大的深层静脉形成血块，将血液从腿部回流到心臟和肺部的情况。

市场动态：

驱动程式和限制

科技进步的崛起

技术进步透过提高支架手术的有效性、安全性和寿命来推动全球静脉支架市场的成长。镍钛诺等生物相容性合金可增强灵活性和耐用性，减少併发症。药物洗脱支架释放药物以防止再狭窄，从而减少重复手术的需要。自扩张式支架和球囊扩张式支架在微创手术中易于使用，从而实现更快的恢復时间和更好的患者体验。

此外，支架设计的技术进步是不可避免的，并且可能超过资料收集的速度。目前的支架主要是雷射切割镍钛合金设计，也有一些开放式和混合式设计。未来的设计可能会结合药物涂层和替代设计来影响泊松效应或流动等因素。了解导致通畅丧失的因素以及支架血栓形成和闭塞的生物机制对于预防支架失效至关重要。

併发症和再狭窄的风险

由于併发症和再狭窄的风险，全球静脉支架市场正面临一些併发症，这引发了有关静脉支架手术的长期有效性和安全性的问题。儘管支架技术取得了进步，但支架血栓、感染或静脉重新狭窄等障碍仍然存在，可能会导致进一步的手术、长时间的恢復或一些手术干预。这种恐惧有时会针对患者甚至医疗保健提供者，有时不考虑静脉支架作为一种选择。因此，它的采用率相当缓慢，并限制了整体市场潜力。这推动了静脉测试在医疗保健行业的出现和接受度。

有关此报告的更多详细资讯 - 索取样品

Boston Scientific Corporation
Cook Medical
Terumo Corporation
Becton, Dickinson and Company (BD)
Abbott Laboratories
Cordis Corporation(Cardinal Health)
Vesper Medical
Bentley
Optimed Medizinische Instrumente GmbH
Similar data will be provided for each market player.
内多洛吉克斯
- 管道产品说明
- 产品关键绩效指标 (KPI)
- 主要活动
- 市场进入时间表
- 产品渗透率
- 销售估算与预测
环球医疗
主动脉有限公司
操作内
乔泰克有限公司
将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录

Product Code: MD8057

The global venous stents market reached US$ 1.24 billion in 2024 and is expected to reach US$ 2.62 billion by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

Venous stents are expandable metal mesh tubes which apply pressure to walls of blocked or narrowed veins and act as a scaffold to keep the veins open. They are usually placed in the bigger central veins located in the abdomen, chest, and legs. Venous stents are used to treat chronic deep vein thrombosis (DVT), hemodialysis/arteriovenous fistulae, May-Thurner syndrome, Nutcracker syndrome, and post-thrombotic syndrome. DVT is defined as the condition where a blood clot develops in one of the large, deep veins, which brings back blood from the leg to the heart and lungs.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

Technological advancements are driving the global venous stents market growth by improving the effectiveness, safety, and longevity of stenting procedures. Biocompatible alloys like nitinol enhance flexibility and durability, reducing complications. Drug-eluting stents release medication to prevent restenosis, reducing the need for repeat procedures. Self-expanding and balloon-expandable stents provide ease of use during minimally invasive surgeries, allowing quicker recovery times and better patient experiences.

Moreover, technological advancements in stent design are inevitable and likely to outpace data collection. Current stents are mainly laser-cut nitinol designs, with some open and hybrid designs. Future designs may incorporate drug coating and alternative designs to influence factors like the Poisson effect or flow. Understanding factors driving patency loss and the biological mechanism of stent thrombosis and occlusion is crucial for stent failure prevention.

Risk of Complications and Restenosis

The global venous stents market is facing some complications due to the risk of complications and restenosis, which instigate questions regarding the long-term effectiveness and safety of venous stenting procedures. Even though there has been technological advancement in stents, barriers such as stent thrombosis, infection, or re-narrowing of the vein still exist and might lead to further procedures, prolonged recovery, or some surgical intervention. This fear sometimes turns out towards the patient or even the healthcare provider and sometimes does not consider venous stents as an option. Hence, it has a rather slow adoption rate and limits overall market potential. This stems the emergence and acceptance of venous stests in the healthcare industry.

For more details on this report - Request for Sample

Segment Analysis

The global venous stents market is segmented based on product type, material, application end user and region.

Product Type:

Covered Stents from the device segment is expected to dominate the Venous Stents market share

The covered stents segment holds a major portion of the venous stents market share and is expected to continue to hold a significant portion of the venous stents market share during the forecast period.

Covered stents are a vital segment in the global market for venous stents, by offering further protection from restenosis and other complications. Covered stents differ from bare metal stents in that their luminal surfaces are lined with a synthetic material to physically restrict tissue ingrowth, thereby reducing the risk of thrombosis, preventing re-narrowing of a vein. Thus they can be ideal for use in complicated situations, such as stenosis of large veins, or those susceptible to occlusion. In fact, covered stents are often preferred in high-risk patients due to the better long-term patency and likelihood of re-treatment.

For instance, in October 2023, Getinge has launched its iCast covered stent system for treating iliac arterial occlusive disease in the US, having received FDA premarket approval in March 2023. The balloon expandable polytetrafluoroethylene-covered stent is marketed outside the US as Advanta V12, according to Getinge.

End User:-

Hospitals segment is the fastest-growing segment in Venous Stents market share

The oncology segment is the fastest-growing segment in the venous stents market share and is expected to hold the market share over the forecast period.

Hospitals are the major healthcare providers in the global venous stents market by offering interventional radiology, vascular surgery, and cardiology in specialty services. Hospitals provide infrastructure and medical expertise for safe stent implantation by proper patient selection and post-procedural care. The increasing number of patients diagnosed with venous conditions has become a demand driver for venous stenting procedures, such as chronic venous insufficiency and deep vein thrombosis. Hospitals also train patients and physicians on the advantages and disadvantages of stenting. With the adoption of advanced stenting technologies, it can contribute to the market growth and acceptance of such forms of treatment.

Geographical Analysis

North America is expected to hold a significant position in the Venous Stents market share

North America holds a substantial position in the venous stents market and is expected to hold most of the market share due to advanced healthcare infrastructure accompanied by increasing prevalence of venous diseases such as DVT and CVI. Moreover, product launches, ongoing studies, demand for advanced treatment solutions is complemented by the geriatric population and alarming obesity statistics helps in the region growth. The sophisticated reimbursement mechanisms and the forceful active market players are conducive to a stimulating atmosphere for the development of innovative stent technologies while increased awareness channels between minimally invasive treatment options.

For instance, in March 2023, W. L. Gore & Associates has enrolled the first U.S. patient in a prospective, non-randomized, multicenter, single-arm study to evaluate the GORE VIAFORT Vascular Stent for treating symptomatic inferior Vena Cava obstruction with or without combined Iliofemoral Obstruction.

Hence, W. L. Gore & Associates is ongoing clinical trials on the GORE VIAFORT Vascular Stent, aiming to improve treatment options for venous obstructions and stimulate market growth by validating new therapeutic approaches and improving patient care outcomes.

Europe is growing at the fastest pace in the Venous Stents market

Europe holds the fastest pace in the venous stents market and is expected to hold most of the market share due to launches of significant products, healthcare expenditures, and development in the medical technology field. Hence, these factors drive the venous market for stents in Europe. Other factors that will drive the market include an aging population, government programs for chronic diseases, and the progress of clinical trials. A highly systematized and organized health structure provides timely diagnosis and treatment, thus increasing the venous stent uptake in Europe.

For instance, in June 2024 Philips has successfully implanted the Duo Venous Stent System, an implantable medical device designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency, following premarket approval from the U.S. FDA.

Competitive Landscape

The major global players in the venous stents market include Medtronic Plc, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Becton, Dickinson and Company (BD), Abbott Laboratories, Cordis Corporation(Cardinal Health), Vesper Medical, Bentley, Optimed Medizinische Instrumente GmbH and among others.

Key Developments

In April 2024, Getinge has received EU MDR certification for its Advanta V12 covered stent system, which is used for patients with aortoiliac occlusive disease, including aortic bifurcation lesions. This certification confirms the system's compliance with EU regulations and reflects Getinge's commitment to quality and patient safety.
In July 2023, Steven Abramowitz, MD, at MedStar Washington Hospital Center, completed the first deep venous stent thrombosis procedures using a minimally invasive thrombectomy catheter, RevCore, which received FDA clearance in March and was officially launched in June. The stent cleaner is a deep venous "stent cleaner."

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global venous stents market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Material Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Material
3.3. Snippet by Applications
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Risk of Complications and Restenosis
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Covered Stents*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Self-Expanding Stents
6.4. Balloon-Expandable Stents
6.5. Bare Stents

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. Nitinol*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Metal Stents
7.4. Stainless Steel
7.5. Polymers
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Deep Vein Thrombosis (DVT)*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Chronic Venous Insufficiency (CVI)
8.4. Pulmonary Embolism (PE)
8.5. Tumor Occlusion
8.6. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. Medtronic Plc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. Boston Scientific Corporation
12.3. Cook Medical
12.4. Terumo Corporation
12.5. Becton, Dickinson and Company (BD)
12.6. Abbott Laboratories
12.7. Cordis Corporation(Cardinal Health)
12.8. Vesper Medical
12.9. Bentley
12.10. Optimed Medizinische Instrumente GmbH
Similar data will be provided for each market player.

Emerging Market Players

12.11. Endologix*
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. Medi-Globe
12.13. Aortic Ltd
12.14. Intra-Op
12.15. Jotec GmbH
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

12.1 About Us and Services
12.2 Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球静脉支架市场 - 2025-2033

Global Venous Stents Market - 2025-2033

市场动态：

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：依产品类型

第 7 章：按材料

第 8 章：按申请

第 9 章：最终用户

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介